Ditchcarbon
  • Contact
  1. Organizations
  2. Hoffmann-La Roche Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

Hoffmann-La Roche Inc. Sustainability Profile

Company website

Hoffmann-La Roche Inc., commonly known as Roche, is a leading global healthcare company headquartered in the United States. Founded in 1896, Roche has established itself as a pioneer in the pharmaceutical and diagnostics industries, with significant operations across North America, Europe, and Asia. The company is renowned for its innovative contributions to oncology, immunology, and infectious diseases, offering a diverse portfolio of prescription medicines and cutting-edge diagnostic tools. Roche's commitment to research and development has led to numerous breakthroughs, positioning it as a market leader in personalised healthcare. Notable achievements include the development of targeted therapies and advanced diagnostics that enhance patient outcomes. With a strong emphasis on innovation and quality, Hoffmann-La Roche Inc. continues to shape the future of healthcare, making a lasting impact on global health.

DitchCarbon Score

How does Hoffmann-La Roche Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

83

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Hoffmann-La Roche Inc.'s score of 83 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.

91%

Let us know if this data was useful to you

Hoffmann-La Roche Inc.'s reported carbon emissions

Inherited from Roche Holding AG

Hoffmann-La Roche Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Roche Holding AG, which influences its climate commitments and emissions reporting. As part of its climate strategy, Hoffmann-La Roche Inc. inherits emissions data and reduction targets from Roche Holding AG. However, no specific reduction targets or achievements have been documented for Hoffmann-La Roche Inc. at this time. The company is aligned with industry standards and initiatives, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Roche Holding AG. While specific emissions figures are not provided, Hoffmann-La Roche Inc. is committed to addressing climate change through its parent company's initiatives. The absence of detailed emissions data highlights the need for ongoing transparency and accountability in corporate climate commitments.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20132014201520162017201820192020202220232024
Scope 1
403,136,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
-
-
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
Scope 3
188,924,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
0,000,000,000
0,000,000,000
0,000,000,000

How Carbon Intensive is Hoffmann-La Roche Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Hoffmann-La Roche Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Hoffmann-La Roche Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Hoffmann-La Roche Inc. is in US, which has a low grid carbon intensity relative to other regions.

Hoffmann-La Roche Inc.'s Scope 3 Categories Breakdown

Hoffmann-La Roche Inc.'s Scope 3 emissions, which decreased by 8% last year and increased significantly since 2013, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
71%
Capital Goods
10%
Upstream Transportation & Distribution
5%
End-of-Life Treatment of Sold Products
4%
Use of Sold Products
4%
Business Travel
3%
Fuel and Energy Related Activities
1%
Employee Commuting
1%
Investments
1%
Waste Generated in Operations
<1%

Hoffmann-La Roche Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Hoffmann-La Roche Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Hoffmann-La Roche Inc.'s Emissions with Industry Peers

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

TerSera Therapeutics LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy